unknown
Stage
About
Genome Biologics develops therapeutic targets and discovers drugs for cardiovascular and cardiometabolic diseases, using integrated technology platforms to accelerate the development of novel therapies for conditions with limited or no existing treatments.
Explore Genome Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.